Quest Diagnostics Incorporated
Quest Diagnostics Incorporated
Quest Diagnostics Incorporated
DGX
DGX
NYSE
Health Services
Services to the Health Industry
227.86
USD
-0.04
-0.02%
Ditutup: 07-24 20:00 (UTC+0)
227.86
USD
+0
+0.00%
Setelah jam pasar: 07-25 00:00 (UTC+0)

DGX Statistik Utama

Tinggi
233.21
Buka
228.00
Volume
1.54M
Rendah
223.42
Cierre anterior
227.90
Nilai Perdagangan
353.86M
Tertinggi 52M
237.78
Volume relatif
1.414
Amplitudo (%)
4.30%
Terendah 52M
165.78
Tingkat Perputaran
1.39%
Kap Pasar
25.14B
P/E (TTM)
24.17
P/E (Tahunan)
25.689
P/B
3.35
P/S
2.18
Laba per Saham (EPS)
9.427
Dividen (TTM)
3.737
Imbal Hasil Dividen
1.44%
Saham beredar
110.69M
Mata uang
USD

DGX Kinerja Harga

7 hari
30 hari
90 hari
180 hari
Sejak awal tahun
1 Tahun
DGX Distribusi Arus Dana
DGX Volume Short Sale Harian
DGX Riwayat Short Interest
As of 2026-07-26, the Quest Diagnostics Incorporated (DGX) stock price today is 227.86. Based on this price, the company has a market capitalization of $25.14B, with a P/E ratio of 24.17. On 2026-07-26, DGX traded between 223.42 and 233.21. Today’s stock price is 1.99% above the daily low and 2.29% below the daily high, placing DGX di sekitar bagian tengah de its most recent trading range. Trading volume currently stands at 1.54M, compared with an average daily volume of 1.09M. This suggests that trading activity is di atas level biasanya than usual. Over the past year, Quest Diagnostics Incorporated shares have traded between 165.78 and 237.78. At today’s price, DGX is 37.45% above its 52-week low and 4.17% below its 52-week high.
Nama Perusahaan
Quest Diagnostics Incorporated
Sektor
Health Services
Industri
Services to the Health Industry
Bursa
NYSE
Jumlah Karyawan
57,000
Ukuran Lot
100
Mata uang
USD
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

DGX FAQ

Cari
Lebih